English 
Deutsch We promote the responsible use of cannabis and safe access.
Stefan Fritsch | Founder & CEO
The Grünhorn Group was founded by Stefan Fritsch and serves as an extensive umbrella brand setting new standards in various areas of the cannabis industry. This includes entities such as Grünhorn Apotheke, canymed GmbH, and Schurer Pharma & Kosmetik GmbH. Under the umbrella of the Grünhorn Group, new standards are continuously set, and innovative concepts for the cannabis industry are developed, enhancing both the quality and availability of medical cannabis.
Each entity under the umbrella of the Group plays a crucial role in this mission. These include:
- the Grünhorn Pharmacy
- the canymed GmbH and
- the Schurer Pharma & Kosmetik GmbH.
Stefan Fritsch's expertise forms the foundation for the group's innovations and developments. Fritsch, a graduate of Northeastern University in Boston with a degree in Finance and Entrepreneurship, brings extensive experience from the pharmaceutical industry, including his work in the Chinese market. In 2020, he founded Grünhorn with a small team in an unused gym. Today, Grünhorn has grown into the largest cannabis group in Germany.
Grünhorn Pharmacy
Grünhorn pharmacy is one of the largest and most renowned providers of medical cannabis in Germany.
Read more
Founded in 2020 in Leipzig, this innovative online pharmacy was already fulfilling one in four medical cannabis prescriptions in Germany before partial legalization in 2023. Following the removal of cannabis from the Narcotics Act in April 2024 and the subsequent lowering of barriers for patients (including those with common conditions like migraines), the order volume has multiplied. This increase has been managed through a disruptive automation approach, a digital warehouse, and an expanded workforce. Thanks to its comprehensive offerings and innovative strategies, Grünhorn has established itself as a pioneer in the field of medical cannabis.
With a wide range of cannabis flowers from various manufacturers, Grünhorn Apotheke provides physicians and patients with an exceptional selection to ensure the best possible therapy. Through close collaboration with renowned growers and its own research into terpenes and active ingredients, Grünhorn has developed proprietary cannabis strains specifically tailored to meet the needs of its patients.
In addition to cannabis flowers, Grünhorn Apotheke also offers its own full-spectrum extracts and capsules for oral consumption. These products are noted for their longer duration of effect and are particularly discreet in use—ideal for patients for whom vaporizing or inhaling cannabis is not an option. All proprietary products are manufactured under the strictest quality controls to ensure the highest pharmaceutical standards. The pharmacy is also deeply involved in its own research and education on cannabis-related topics. The Grünhorn Academy and its in-house laboratory contribute to further exploring and making the therapeutic potential of medical cannabis accessible.
The independent contract pharmacy is the Paunsdorf Pharmacy, located in the Paunsdorf Center in Leipzig, and managed by Kirsten Fritsch.
Every fourth prescription for cannabis flowers goes through us.
This makes us the largest German pharmacy for medicinal cannabis and the first to meet the high demand through automation.
Market leader
- over 20 % of the cannabis volume in Germany
- We dispense approx. 4 to 5 tons of cannabis to patients every year
Wide range
- As part of the Grünhorn Group, Grünhorn-Apotheke is the largest pharmacy producing full-spectrum extracts and capsules from its own laboratory*.
- We stock over 100 flower varieties and 60 different extracts and capsules.
Disruption through digitalization
- Gentle, semi-automated filling of the cannabis flowers
- Digital warehouse
- Business Intelligence
canymed GmbH
canymed GmbH is your reliable pharmaceutical wholesaler for medical cannabis, supplying pharmacies, medical practices, and hospitals nationwide. "We place the highest value on consistently high quality in accordance with the requirements of the German Pharmacopoeia and carefully select our partners accordingly," says Matthias Fischer, Managing Director of canymed GmbH.
Read more
As a licensed and fully authorized pharmaceutical wholesaler in Germany (§52a AMG) for narcotics (§3 BtMG), canymed offers personalized consultation to ensure the supply security of pharmacies and patients at all times. Additionally, canymed GmbH is also active as a manufacturer in accordance with §13 AMG. The company is recognized for its significant research and demand potential, particularly in the treatment of patients suffering from pain, epilepsy, spasticity, multiple sclerosis, or rheumatism. It is known for its nationwide sales force, certified under AMG §75, providing expert consultation services to physicians and pharmacists.
Matthias Fischer is a global business leader with over two decades of experience in technology and healthcare. As the Founder and Managing Director of canymed GmbH, he has been instrumental in developing the company into a leading player in the pharmaceutical sector, specializing in the distribution and development of medical cannabis products. canymed.com is a fully licensed pharmaceutical wholesaler and manufacturer of medical cannabis based in Leipzig. Before founding canymed GmbH, Matthias Fischer held key executive positions in several renowned companies, including COO of Simplifa GmbH, Director of Go-to-Market for the Scout24 Group, and various senior leadership roles at Vodafone Global & Germany.
SCHURER PHARMA & KOSMETIK GmbH
Schurer Pharma & Kosmetik GmbH (SPK) is a leading provider of automated fulfillment and logistics services for pharmacies that distribute cannabis products.
Read more
As a fulfillment service provider, SPK manages a wide range of processes across the entire supply chain for its clients. This includes the storage, picking, packaging, and shipping of cannabis products to pharmacies, as well as handling returns and inventory management. By automating these processes, SPK ensures efficient and error-free order processing, allowing pharmacies to fully focus on customer care.
The company is based in Leipzig and has played a key role in the conception and strategic development of the Grünhorn Group, an innovative supplier of cannabis products. The CEOs of SPK Stefan Fritsch (more information above) and Sven-Roger von Schilling, who has over 20 years of international leadership experience in the healthcare, renewables, and IT services industries. As an experienced company founder and CFO of Grünhorn, he excels in guiding aspiring companies through ambitious growth phases and positioning them for sustainable success.
Sven has successfully IPO-ed three companies on the Frankfurt Stock Exchange and advised numerous others on IPO and SPAC projects. His extensive expertise and strategic acumen have significantly contributed to the development and expansion of the companies he has led. Sven holds an MBA from the J.L. Kellogg School of Management, further underscoring his qualifications as a leading financial expert and business advisor.
*Status of the survey: 2023
